Clinical Trial Update: Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles [Phase 4]

View source ↗

Summary

A Phase 4 randomized neoadjuvant trial evaluating Initumab in combination with Pyrrotinib and chemotherapy for HER2-positive breast cancer; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapeutic agents
• Initumab
• Pyrrotinib

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: HER2 Positive Breast Cancer | Phase 4 | Status: NOT_YET_RECRUITING